Clinical Trials Update: March 29, 2011 - U.S. News World Report Print
U.S. News & World Report
This study will evaluate the effects of febuxostat versus placebo in gout patients with hyperuricemia and moderate-to-severe renal impairment. Male candidates must be 18 or older; female candidates must be 45 or older. This study is for people who have

...